These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 6594925)
41. Pharmacology, clinical efficacy and adverse effects of vindesine sulfate, a new vinca alkaloid. Cersosimo RJ; Bromer R; Licciardello JT; Hong WK Pharmacotherapy; 1983; 3(5):259-74. PubMed ID: 6359081 [TBL] [Abstract][Full Text] [Related]
42. Vindesine-prednisone in the treatment of blast crisis of chronic myeloid leukemia. Lemoine F; Najman A; Laporte JP; Gorin NC; Duhamel G Cancer Treat Rep; 1985 Feb; 69(2):203-4. PubMed ID: 3855698 [TBL] [Abstract][Full Text] [Related]
43. Vindesine: a new vinca alkaloid. Bayssas M; Gouveia J; de Vassal F; Misset JL; Schwarzenberg L; Ribaud P; Musset M; Jasmin C; Hayat M; Mathé G Recent Results Cancer Res; 1980; 74():91-7. PubMed ID: 7003662 [TBL] [Abstract][Full Text] [Related]
44. [Vindesine plus L-asparaginase and prednisolone therapy (VDS-VLP therapy) for remission induction in children with relapsed acute lymphoblastic leukemia]. Hara T; Koike K; Tsukada M; Komiyama A; Akabane T Rinsho Ketsueki; 1983 May; 24(5):540-6. PubMed ID: 6577209 [No Abstract] [Full Text] [Related]
45. Improved survival rate in children with stage III and IV B cell non-Hodgkin's lymphoma and leukemia using multi-agent chemotherapy: results of a study of 114 children from the French Pediatric Oncology Society. Patte C; Philip T; Rodary C; Bernard A; Zucker JM; Bernard JL; Robert A; Rialland X; Benz-Lemoine E; Demeocq F J Clin Oncol; 1986 Aug; 4(8):1219-26. PubMed ID: 3525767 [TBL] [Abstract][Full Text] [Related]
46. [A case of refractory acute lymphocytic leukemia who achieved a complete remission by mitoxantrone]. Yoshikawa H; Sao H; Tahara T; Akao Y; Yoshikawa S Gan To Kagaku Ryoho; 1984 Mar; 11(3):515-20. PubMed ID: 6584088 [TBL] [Abstract][Full Text] [Related]
47. Combination of vindesine and prednisone in malignant lymphoma and acute leukemia. Raich PC; Walker BK; Rogers JS; Subramanian VP; Fontana JA; Knost JA; Denning B Cancer Treat Rep; 1983 May; 67(5):485-7. PubMed ID: 6573959 [TBL] [Abstract][Full Text] [Related]
48. Vindesine, etoposide (VP-16), and prednisolone (VEP) in relapsed patients with grade II non-Hodgkin's lymphoma. Hancock BW Semin Oncol; 1985 Mar; 12(1 Suppl 2):26-8. PubMed ID: 3975655 [TBL] [Abstract][Full Text] [Related]
49. Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease. Chao NJ; Schmidt GM; Niland JC; Amylon MD; Dagis AC; Long GD; Nademanee AP; Negrin RS; O'Donnell MR; Parker PM N Engl J Med; 1993 Oct; 329(17):1225-30. PubMed ID: 8413388 [TBL] [Abstract][Full Text] [Related]
51. [Phase II and III studies of vindesine in children with leukemia and lymphoma]. Ise T; Akabane T; Fujimoto T; Sakurai M; Taguchi N; Miyazaki T; Hattori M; Ito M; Masaoka T; Maekawa T Rinsho Ketsueki; 1986 Feb; 27(2):149-57. PubMed ID: 3522957 [No Abstract] [Full Text] [Related]
52. Vindesine trials at Memorial Sloan-Kettering Cancer Center. Young CW Cancer Treat Rev; 1980 Sep; 7 Suppl 1():53-7. PubMed ID: 7438122 [No Abstract] [Full Text] [Related]
53. Dyspnea following vinblastine or vindesine administration in patients receiving mitomycin plus vinca alkaloid combination therapy. Kris MG; Pablo D; Gralla RJ; Burke MT; Prestifilippo J; Lewin D Cancer Treat Rep; 1984; 68(7-8):1029-31. PubMed ID: 6744336 [TBL] [Abstract][Full Text] [Related]
54. Acute leukemia in children. Model for the development of scientific methodology for clinical therapeutic research in cancer. Frei E Cancer; 1984 May; 53(10):2013-25. PubMed ID: 6367931 [No Abstract] [Full Text] [Related]
55. Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center. Mora J; Filippa DA; Qin J; Wollner N Cancer; 2003 Sep; 98(6):1283-91. PubMed ID: 12973853 [TBL] [Abstract][Full Text] [Related]
56. Modified Capizzi maintenance regimen in children with relapsed acute lymphoblastic leukaemia. Pinkerton CR; Mills S; Chessells JM Med Pediatr Oncol; 1986; 14(2):69-72. PubMed ID: 3458998 [TBL] [Abstract][Full Text] [Related]
57. Broad phase II study of vindesine. Valdivieso M; Bedikian AY; Bodey GP; Freireich EJ Cancer Treat Rep; 1981; 65(9-10):877-9. PubMed ID: 7273021 [TBL] [Abstract][Full Text] [Related]
58. Development of a new intensive therapy for acute lymphoblastic leukemia in children at increased risk of early relapse. The Memorial Sloan-Kettering-New York-II protocol. Steinherz PG; Redner A; Steinherz L; Meyers P; Tan C; Heller G Cancer; 1993 Nov; 72(10):3120-30. PubMed ID: 8221579 [TBL] [Abstract][Full Text] [Related]
59. Treatment of acute lymphoblastic leukemia in childreq with "prophylactic" intrathecal methotrexate and intensive systemic chemotherapy. Haghbin M; Tan CT; Clarkson BD; Miké V; Burchenal JH; Murphy ML Cancer Res; 1975 Mar; 35(3):807-11. PubMed ID: 1054287 [TBL] [Abstract][Full Text] [Related]
60. Phase II study of vindesine, cisplatin, and hexamethylmelamine (VCH) in small cell carcinoma of the lung. Daugaard G; Hansen HH; Rørth M Cancer Treat Rep; 1984 Sep; 68(9):1179-81. PubMed ID: 6090016 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]